Hormonal influence on coenzyme Q 10 levels in blood plasma

International Journal of Molecular Sciences

Volumn 12, Issue 12, 2011, Pages 9216-9225

  Mancini, Antonio ^a   Festa, Roberto ^b   Raimondo, Sebastiano ^a   Pontecorvi, Alfredo ^a   Littarru, Gian Paolo ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Antioxidants; Coenzyme Q 10; Oxidative stress; Pituitary; Thyroid

Indexed keywords

CATALASE; CERULOPLASMIN; FERRITIN; GLUTATHIONE PEROXIDASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANSFERRIN; UBIDECARENONE; VERY LOW DENSITY LIPOPROTEIN; CORTICOSTEROID; SEX HORMONE; THYROID HORMONE; UBIQUINONE;

ADRENAL DISEASE; ANTIOXIDANT ACTIVITY; BINDING AFFINITY; BINDING SITE; BIOACCUMULATION; BIOENERGY; BIOSYNTHESIS; BLOOD LEVEL; CHEMICAL STRUCTURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME ACTIVITY; GONADAL DISEASE; GROWTH HORMONE DEFICIENCY; HOMEOSTASIS; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LIPID PEROXIDATION; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; OXIDATIVE STRESS; REVIEW; SCANNING ELECTRON MICROSCOPY; SENSITIVITY ANALYSIS; ANALOGS AND DERIVATIVES; BLOOD; ENDOCRINE DISEASE; METABOLISM;

ADRENAL CORTEX HORMONES; ENDOCRINE SYSTEM DISEASES; GONADAL HORMONES; HUMANS; THYROID HORMONES; UBIQUINONE;

EID: 84055193840     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12129216     Document Type: Review

References (41)

1. Crane, F.L. Biochemical functions of coenzyme Q10. J. Am. Coll. Nutr. 2001, 20, 591-598.
2. Kaltschmidt, B.; Sparna, T.; Kaltschmidt, C. Activation of NFκB by reactive oxygen intermediates in the nervous system. Antioxid. Redox Signal. 1999, 1, 129-144.
3. Littarru, G.P.; Tiano, L. Clinical aspects of coenzyme Q10: An update. Nutrition 2010, 26, 250-254.
4. Littarru, G.P.; Mosca, F.; Fattorini, D.; Bompadre, S.; Battino, M. Assay of coenzyme Q10 in plasma by a single dilution step. Methods Enzymol. 2004, 378, 170-176.
5. Mancini, A.; Festa, R.; Di Donna, V.; Leone, E.; Littarru, G.P.; Silvestrini, A.; Meucci, E.; Pontecorvi, A. Hormones and antioxidant systems: Role of pituitary and pituitary-dependent axes. J. Endocrinol. Invest. 2010, 33, 422-433.
6. Littarru, G.P. The Mitochondrion: A Main Energy Plant. In Energy and Defence; CESI: Roma, Italy, 1994; pp. 14-21.
7. Littarru, G.P. Radical Formation in vivo. In Energy and Defence; CESI: Roma, Italy, 1994; pp. 28-30.
8. Kang, D.; Hamasaki, N. Mitochondrial oxidative stress and mitochondrial DNA. Clin. Chem. Lab. Med. 2003, 41, 1281-1288.
9. Turrens, J.F.; Boveris, A. Generation of superoxyde anion by the NADH dehydrogenase of bovine mitochondria. Biochem. J. 1980, 191, 421-427.
10. Cross, A.R.; Jones, O.T.G. Enzymic mechanism of superoxyde production. Biochem. Biophys. Acta 1991, 1057, 281-284.
11. Wolff, S.P.; Jiang, Z.Y.; Hunt, J.V. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radical. Biol. Med. 1991, 10, 339-352.
12. Littarru, G.P. Antioxidant Mechanisms. In Energy and Defence; CESI: Roma, Italy, 1994; pp. 42-45.
13. Thomas, S.R.; Witting, P.K.; Stocker, R. A role for reduced coenzyme Q in atherosclerosis? Biofactors 1999, 9, 207-224.
14. Stocker, R.; Bowry, V.W.; Frei, B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc. Natl. Acad. Sci. USA 1991, 88, 1646-1650.
15. Mohr, D.; Bowry, V.W.; Stocker, R. Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation. Biochim. Biophys. Acta 1992, 1126, 247-254.
16. Lakka, H.M.; Laaksonen, D.E.; Lakka, T.A.; Niskanen, L.K.; Kumpusalo, E.; Tuomilehto, J.; Salonen, J.T. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288, 2709-2716.
17. Isomaa, B.; Almgren, P.; Tuomi, T.; Forsén, B.; Lahti, K.; Nissén, M.; Taskinen, M.R.; Groop, L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24, 683-689.
18. Griffth, R.L.; Virella, G.T.; Stevenson, H.C.; Lopes-Virella, M.F. Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation. J. Exp. Med. 1988, 168, 1041-1059.
19. Tsai, E.C.; Hirsch, I.B.; Brunzell, J.D.; Chait, A. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 1994, 43, 1010-1014.
20. Tomasetti, M.; Alleva, R.; Solenghi, M.D.; Littarru, G.P. Distribution of antioxidants among blood components and lipoproteins: Significance of lipids/CoQ10 ratio as a possible marker of increased risk for atherosclerosis. Biofactors 1999, 9, 231-240.
21. Stampfer, M.J.; Hennekens, C.H.; Manson, J.E.; Colditz, G.A.; Rosner, B.; Willett, W.C. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 1993, 328, 1444-1449.
22. Riemersma, R.A.; Wood, D.A.; Macintyre, C.C.; Elton, R.A.; Gey, K.F.; Oliver, M.F. Anti-oxidants and pro-oxidants in coronary heart disease. Lancet 1991, 337, 677.
23. Rimm, E.B.; Stampfer, M.J.; Ascherio, A.; Giovannucci, E.; Colditz, G.A.; Willett, W.C. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 1993, 328, 1450-1456.
24. Singh, R.B.; Wander, G.S.; Rastogi, A.; Shukla, P.K.; Mittal, A.; Sharma, J.P.; Mehrotra, S.K.; Kapoor, R.; Chopra, R.K. Randomized, double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction. Cardiovasc. Drugs Ther. 1998, 12, 347-353.
25. Kuklinski, B.; Weissenbacher, E.; Fähnrich, A. Coenzyme Q10 and antioxidants in acute myocardial infarction. Mol. Aspects Med. 1994, 15, S143-S147.
26. Yalcin, A.; Kilinc, E., Sagcan, A.; Kultursay, H. Coenzime Q10 concentrations in coronary artery disease. Clin. Biochem. 2004, 37, 706-709.
27. Golbidi, S.; Laher, I. Antioxidant therapy in human endocrine disorders. Med. Sci. Monit. 2010, 16, RA9-RA24.
28. Resch, U.; Helsel, G.; Tatzber, F.; Sinzinger, H. Antioxidant status in thyroid dysfunction. Clin. Chem. Lab. Med. 2002, 40, 1132-1134.
29. Ademoglu, E.; Gokkusu, C.; Yarman, S.; Azizlerli, H. The effect of methimazole on oxidants and antioxidants system in patients with hyperthyroidism. Pharmacol. Res. 1998, 38, 93-96.
30. Bianchi, G.; Solaroli, E.; Zaccheroni, V.; Grossi, G.; Bargossi, A.M.; Melchionda, N.; Marchesini, G. Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: effect of treatment. Horm. Metab. Res. 1990, 31, 620-624.
31. Mancini, A.; de Marinis, L.; Calabrò, F.; Fiumara, C.; Goglia, A.; Littarru, G.P. Physiopathological Relevance of Coenzyme Q10 in Thyroid Disorders: CoQ10 Concentrations in Normal and Diseased Human Thyroid Tissue. In Biomedical and Clinical Aspects of Coenzyme Q; Folkers, K., Littarru, G.P., Yamagami, T., Eds.; Elsevier: Amsterdam, The Netherlands, 1991; pp. 441-448.
32. Mancini, A.; Conte, G.; de Marinis, L.; Oradei, A.; Littarru, G.P. Thyroid hormone and oxidative metabolism: Coenzyme Q10 in thyroid's disease. Coenzyme Q Biol. Med. 1993, 1, 25-34.
33. Asayama, K.; Kato, K. Oxidative muscular injury and its relevance to hyperthyroidism. Free Radic. Biol. Med. 2000, 8, 293-303.
34. Pandolfi, C.; Ferrari, D., Stanic, I., Pellegrini, L. Circulating levels of CoQ10 in hypo-and hyperthyroidism. Minerva Endocrinol. 1994, 19, 139-142.
35. Mancini, A.; de Marinis, L.; Calabrò, F.; Sciuto, R.; Oradei, A.; Lippa, S.; Sandric, S.; Littarru, G.P.; Barbarino, A. Evaluation of metabolic status in amiodarone-induced thyroid disorders: Plasma coenzyme Q10 determination. J. Endocrinol. Invest. 1989, 12, 511-516.
36. Menke, T.; Niklowitz, P.; Reinehr, T.; de Sousa, G.J.; Andler, W. Plasma levels of coenzyme Q10 in children with hyperthyroidism. Horm. Res. 2004, 61, 153-158.
37. Mancini, A.; Corbo, G.M.; Gaballo, A.; Valente, S.; Gigliotti, P.; Cimino, V.; de Marinis, L.; Principi, F.; Littarru, G.P. Relationships between plasma CoQ10 levels and thyroid hormones in chronic obstructive pulmonary disease. Biofactors 2005, 25, 201-204.
38. Mancini, A.; Bianchi, A.; Fusco, A.; Sacco, E.; Leone, E.; Tilaro, L.; Porcelli, T.; Giampietro, A.; Principi, F.; de Marinis, L.; et al. Coenzyme Q10 evaluation in pituitary-adrenal axis disease: preliminary data. Biofactors 2005, 25, 197-199.
39. Mancini, A.; Leone, E.; Silvestrini, A.; Festa, R.; Di Donna, V.; de Marinis, L.; Pontecorvi, A.; Littarru, G.P.; Meucci, E. Evaluation of antioxidant systems in pituitary-adrenal axis diseases. Pituitary 2010, 13, 138-145.
40. Mancini, A.; Leone, E.; Festa, R.; Grande, G.; Silvestrini, A.; de Marinis, L.; Pontecorvi, A.; Maira, G.; Gianpaolo, L.; Meucci, E. Effects of testosterone on antioxidant systems in male secondary hypogonadism. J. Androl. 2008, 29, 622-629.
41. Mancini, A.; Calabrò, F.; Fiumara, C.; Conte, G.; Oradei, A.; Lippa, S.; de Marinis, L.; Littarru, G.P. Plasma Coenzyme Q1O determination in acromegaly. Exp. Clin. Endocrinol. Life Sci. Adv. 1992, 11, 55-60.